Skip to main content
Erschienen in: Trials 1/2019

Open Access 01.12.2019 | Study protocol

Effects of combining functional exercises with exercise training on daily physical activities and functionality in patients with COPD: a protocol for a randomized clinical trial

verfasst von: Fabiano Francisco de Lima, Carlos Augusto Camillo, Isis Grigoletto, Juliana Souza Uzeloto, Franciele Marques Vanderlei, Dionei Ramos, Ercy Mara Cipulo Ramos

Erschienen in: Trials | Ausgabe 1/2019

Abstract

Introduction

Functional training has been shown to be a viable alternative for the elderly and patients with chronic obstructive pulmonary disease (COPD). However, whether the combination of this type of training with aerobic and resistance training, commonly performed in pulmonary rehabilitation (PR) programs, induces more pronounced effects on daily physical activities and functionality remains unclear. The aims of the study will be to evaluate the short-term and sustained effects of the combination of a functional circuit program with a training program consisting of aerobic and resistance exercise.

Methods

In this randomized controlled trial, patients with COPD will be randomly assigned (1:1:1) to an 8-week training program to follow one of the three a priori defined groups: (I) resistance and aerobic and functional exercises, (II) a conventional program including only resistance and aerobic exercises, or (III) a usual care program. Patients will be evaluated before and upon completion of 8 weeks of training regarding physical activity in daily life (PADL) using an activity monitor (accelerometer), activities of daily living (London Chest Activity of Daily Living), functional exercise capacity (6-minute walk test), and muscle strength (dynamometry). Additionally, the sustained effects of the interventions will be evaluated 22 weeks after commencing the study.

Discussion

The inclusion of a protocol of functional physical training in the training conventionally performed by patients with COPD as an alternative to increase PADL and functionality may provide subsidies for the treatment of these patients, representing an advance and impacting on the physical training of patients with COPD.

Trial registration

Brazilian Clinical Trials Registry (ReBEC) ID: RBR-3zmh3r. Registered: March 7, 2018.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s13063-019-3780-y.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
1RM
1-repetition maximum
6MWT
6-minute walk test
ADLs
Activities of daily living
ATS
American Thoracic Society
COPD
Chronic obstructive pulmonary disease
CTG
Conventional training group
FCT/UNESP
Universidade Estadual Paulista
FTG
Functional circuit training group
LCADL
London Chest Activity of Daily Living
PADL
Physical activity in daily life
PR
Pulmonary rehabilitation
UCG
Usual care group

Introduction

Despite its primarily respiratory character, chronic obstructive pulmonary disease (COPD) also presents extrapulmonary consequences, including the reduction in functional exercise capacity and musculoskeletal function (i.e., strength and peripheral muscular resistance) [1, 2]. It is known that, to avoid the symptoms of the disease, these patients are less active when compared with healthy individuals of the same age group, presenting less time in physical activity, at a lower intensity and number of movements per day [38]. Lower levels of physical activity in daily life (PADL) are associated with a higher risk of hospitalizations and worse prognosis in COPD [9, 10], besides contributing to the progression of the disease [11].
As an attempt to counteract these consequences, pulmonary rehabilitation (PR) programs including physical training have been proposed as a key element in the treatment of COPD [12, 13]. Physical training is associated with an improvement in the functional exercise capacity and a reduction in dyspnea in these individuals [14, 15]. Resistance and aerobic training are among the exercises commonly proposed for these patients [12, 13, 16]. The combination of these modalities has been shown to be the best form of training for these individuals [17] as well as being recommended by international guidelines for the clinical treatment of these patients in PR programs [13, 18]. Despite the functional gains obtained in PR programs, the evidence for increased PADL in patients with COPD is still contradictory and inconsistent [19], especially in short-term PR programs [2024].
Functional physical training has been shown to be an effective alternative for improving mobility, functionality, and performance in the activities of daily living (ADLs) of older adults [2527]. This type of training includes muscle work involving coordinated patterns of multi-joint movements and dynamic tasks in order to improve functionality. Studies demonstrate positive functional effects of this type of exercise for patients with COPD [22, 28].
Sewell et al. [28] demonstrated improvement in PADL and ADL performance after a short-term training program combining functional exercises with aerobic and home training in patients with COPD. Despite the benefits obtained, the authors did not evaluate whether the responses were maintained for a longer period of time than the program period and did not include the progressive resistance training, an essential component for these patients. It is still unknown whether the addition of a functional circuit training (structured on the basis of the limitations during ADLs) to a conventional combined aerobic and resistance training program, commonly performed and well established in PR programs, can improve PADL, ADL performance, and functionality of patients with COPD in the short term. In addition, it is unknown whether possible functional and PADL gains obtained in this type of training are maintained during a 3-month follow-up.
This randomized clinical superiority trial aims to evaluate the effects of the addition of a circuit of functional physical training to an 8-week combined training (aerobic and resistance) on PADL, ADL performance, functional exercise capacity, and peripheral muscle strength of patients with COPD. In addition, the effects of the interventions will be re-evaluated 3 months after the training completion. It is hypothesized that the proposed functional training will lead to behavioral changes, influencing the improvement in the performance of ADLs and, consequently, PADL, accompanied by functional improvement in patients with COPD.

Methods

Study design

A randomized clinical trial with follow-up will be conducted at the Center for Studies and Care in Physical Therapy and Rehabilitation of the Universidade Estadual Paulista (FCT/UNESP) in Presidente Prudente, Brazil. The study protocol was developed following the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Checklist guidelines (Additional file 1) [29]. The trial was registered at www.​ensaiosclinicos.​gov.​br (ID: RBR-3zmh3r). The study design is shown in Fig. 1.
Initially, participants will participate in an assessment process over 2 weeks on non-consecutive days. The first day of evaluation will consist of anamnesis, obtaining personal identification data and investigation of pre-existing comorbidities, and performing spirometry to confirm the diagnosis of COPD by means of a portable spirometer MIR-Spirobank version 3.6 (MIR - Medical International Research, Roma, Italy). The interpretation will be in accordance with the American Thoracic Society (ATS) and European Respiratory Society (ERS) [30], and values of normality will be relative to the Brazilian population [31]. Limitations of ADLs will be evaluated by the London Chest Activity of Daily Living (LCADL) scale [32, 33]. It should be emphasized that the questionnaire will be applied through an interview, always by the same evaluator, who will carry out prior training to avoid possible biases in the interpretation of questions and answers. On the second day, a functional capacity evaluation will be performed using the 6-minute walk test (6MWT). On the third day of evaluations, the measurement of peripheral muscle strength will be performed by means of a digital dynamometer. Patients will receive a physical activity monitor (accelerometer) which will be used during 7 days before the beginning of the training period, together with the basic guidelines for using the equipment. After the initial evaluation period, the training phase will begin. Conventional sessions will include resistance training and aerobic training. Resistance training plus functional circuit will include resistance training and performing a functional training circuit. Respiratory sessions will include only respiratory physiotherapy techniques.
After the end of the training period (8 weeks), all the evaluations described above, except for the spirometry, will be repeated. Finally, a follow-up will be performed 3 months after the end of the training period, evaluating the PADL, limitations in the performance of ADLs, functional exercise capacity, and muscle strength.

Participants

For this study, 75 patients with COPD from the municipality of Presidente Prudente and the region will be recruited through telephone contact and the distribution of leaflets and medical referrals. The following inclusion criteria will be considered: (1) patients with COPD diagnosed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) [34], (2) clinically stable patients without exacerbations or changes in medications for at least 30 days, (3) patients who do not use long-term oxygen therapy at home, (4) patients without pathological conditions that prevent the performance of physical activity, (5) absence of severe or unstable heart disease, and (6) do not participate in another structured exercise program. The study was approved by the research ethics committee of the FCT/UNESP in Presidente Prudente, Brazil (#77909317.2.0000.5402).

Analysis of the population

Exclusion criteria are complications that prevent the continuity of the training protocol as well as low adhesion rate to the training protocol (below 75% of all sessions) [35]. In the event of two consecutive absences from training sessions, patients will be contacted by telephone to confirm the reason. An intention-to-treat analysis will be performed using the patient’s most recent assessment in case of withdrawals or absence of data. In case of possible injuries occurring during the intervention period, the individuals will be referred for appropriate treatment.

Randomization

The sample will be randomly allocated into three groups: functional circuit training group (FTG), conventional training group (CTG), and usual care group (UCG). The randomized allocation sequence will be performed by a researcher who will not be involved in the recruitment, evaluation, or training of patients, and an online platform (www.​sealedenvelope.​com) and concealed brown envelopes will be used. The randomization process will be carried out in blocks defined a priori. Evaluators will be blind as to the allocation of participants to interventions. The training will be supervised by trained physiotherapists not involved in the randomization process or evaluations.

Procedures

Interventions

The physical exercise program will take place over 8 weeks with a frequency of three weekly sessions of about 60 min each, totaling 24 training sessions. The sessions will begin with dynamic general stretching, after which the aerobic training will be carried out on a treadmill with a duration of 30 min, followed by the resistance training of upper limbs and lower limbs. These dynamics will occur for both the FTG and CTG, except for the third weekly session in which the FTG will perform functional training in circuit format. At the beginning, during, and at the end of the sessions, vital signs will be checked. The UCG will perform only usual care involving respiratory physiotherapy sessions that include inhalation therapy, pulmonary deflation techniques, diaphragmatic awareness, and inspiratory muscle exercise.

Resistance training

For the training prescription, a 1-repetition maximum (1RM) test will be performed, according to a previously described protocol [36, 37], of the following muscle groups: elbow flexors and knee extensors and flexors. The resistance training will be performed using weight machines: extensor chair and flexor chair (Ipiranga® - Brazil) for lower limbs and simple pulley equipment (Ipiranga® - Brazil) for upper limbs. The intensity of training will follow the protocol recommended for patients with COPD [38, 39], 60 to 80% of the 1RM test, with three sets of 10 repetitions, and 2-min intervals between sets. The load increase will be performed every four stimuli (sessions) with a 5% increase in the intensity of the 1RM test until reaching 80%. The trained muscle groups will be the same as previously described in the 1RM test.

Aerobic training

The aerobic training will be performed on an ergometric treadmill and will begin with an intensity of 80% of the average speed reached in the 6MWT [40]. In addition, the increase in aerobic training intensity will be performed on the basis of the subjective sensation of dyspnea of the individuals, measured by the Borg scale [38]. Thus, when the individual reports a dyspnea sensation with values between 4 and 6 on the Borg scale, the intensity will be maintained, this being considered an adequate training intensity [38, 41]; however, when the intensity is less than 4, there will be a 5% increase in training intensity.

Functional circuit training

In order to maintain the same increment dynamics of resistance training in both training groups (FTG and CTG), the session that will include circuit format functional training in the FTG will be divided into two stages: functional circuit and resistance training (elbow flexion, knee extension, and flexion). The circuit training will be composed of 12 exercises (stations) that will simulate ADLs, elaborated on the basis of previous identification (telephone interview) of the main limitations for performing ADLs, reported by patients with COPD from the database of the care center where the study will be conducted.
Each exercise will last 2 min and 30 s, so the total duration of the functional circuit will be 30 min, as performed in aerobic training. Following the same method of aerobic training, the increment in the training intensity will be performed on the basis of the subjective sensation of dyspnea of the individuals, measured using the Borg scale [38, 41]. Thus, when the individual reports a dyspnea sensation with values between 4 and 6 on the Borg scale, the intensity will be maintained, this being considered an adequate training intensity [38, 41]; however, when the intensity is less than 4, the training intensity will be increased (that is, an increase in the speed/number of repetitions of the exercises until the 8 weeks of training is completed). A pilot session was conducted with patients with COPD to evaluate the viability and execution time of functional training in circuit format. There were no problems in the execution and time of the exercises and these were shown to be feasible by the patients.
The functional circuit will include the exercises/stations described below and illustrated in Fig. 2:
Exercise 1: Simulate drying the back: pass the stick behind the back (as if drying the back with a towel) and change hands every five movements.
Exercise 2: Simulate sweeping the floor: With shoulder flexion at about 75°, hold the stick with the forearm pronated and perform a movement similar to “rowing”.
Exercise 3: Simulate tying shoes: Sitting in a chair with 90° elbow flexion, hold a ball with the hands, then perform knee flexion, touching the lateral malleolus on the contralateral knee, with the ball touching the medial malleolus.
Exercise 4: Simulate passing a squeegee on the floor: Holding a stick (the stick should touch the ground) with the hands, move the stick anteriorly to the left and then to the right and then repeat on the contralateral side.
Exercise 5: Simulate bath movements to wash the hair: Holding a small ball in the hands, perform simultaneous movements: 90° shoulder flexion, 90° elbow flexion, and touch the ball on the head.
Exercise 6: Simulate picking up objects in high and low places: In front of a bookcase in the orthostatic position, pick up a ball from a high shelf (head level) and then put it on two lower shelves (chest level and waist level).
Exercise 7: Simulate squatting: Squat holding a fixed bar.
Exercise 8: Simulate walking on uneven ground using ramps and stairs: Rise and descend steps/ramp.
Exercise 9: Simulate standing up and sitting in a chair: Get up from the chair, walk a short distance (3 m), and sit in the chair again.
Exercise 10: Simulate changing clothes: With a hula hoop on the ground, step with both feet inside the circle, crouch to pick up the hula hoop with both hands, rise up holding the hula hoop, and perform shoulder flexion by lifting the hula hoop so that it runs all over the body of the individual; reverse the movement with the same steps, ending by placing it on the floor again.
Exercise 11: Simulate the avoidance of obstacles during gait: With five hula hoops on the ground, walk among the hula hoops.
Exercise 12: Simulate picking up objects: In front of three small cones on the floor, perform trunk flexion and touch the tip of one of the cones and return to the starting position and repeat the movement until having touched all the cones. When finishing the three movements, perform them with the other hand (Fig. 2).

Participant timeline

The time schedule of enrollment, interventions, and assessments is outlined in Fig. 3. Recruitment of study participants began in July 2018.

Results

The primary outcome will be the PADL assessment using accelerometry. Secondary outcomes are limitations on performance in ADLs, functional exercise capacity, and peripheral muscle strength. The evaluations will be carried out by the same evaluators at all described moments.

Primary outcome

The PADL will be used as the primary outcome of the study, measured by step counts days and time spent on activities, using an accelerometer-type movement sensor, ActiGraph GT3X (ActiGraph LLC, Pensacola, FL, USA), which measures and records acceleration variations with magnitudes ranging from approximately 0.05 to 2.5 G (g = 9.8 m/s [2]) within a frequency range of 0.25 to 2.5 Hz. Each sample of counts will be summarized over a specific time interval of 60 s, called an epoch. Accelerometers will be placed on the waist immediately below the umbilical scar, and individuals will wear the equipment for 7 days. The accelerometer will be removed during the nighttime sleep period and when the participant has contact with water (personal hygiene or water activities). Participants will wear the device before and after the intervention periods and soon after the 3-month post-intervention follow-up. For analysis of the data, specific software will be used (ActiLife5 – Data Analysis Software by ActiGraph).

Secondary outcomes

The study will have three evaluations of secondary outcomes: limitations during ADL performance, functional exercise capacity, and peripheral muscle strength. These outcomes will be evaluated before and after the intervention period as well as after the post-intervention follow-up period of 3 months.

Limitations during activities of daily living

Limitations during the performance of ADLs will be evaluated by the LCADL scale, developed by Garrod et al. (2000) [42], translated to Portuguese, and validated for use in COPD in Brazilian patients [32, 33]. This scale contains 15 items divided into four domains: personal care (four items), domestic (six items), physical activity (two items), and leisure (three items) [33]. The total score can vary from 0 to 75 points, and the higher the score, the greater the limitation in ADLs [32].

Functional exercise capacity

Functional exercise capacity will be evaluated through the 6MWT, performed in accordance with the guidelines established by the ATS [43].

Peripheral muscle strength

Measurement of muscle strength will be performed in the dominant member by using a Force Gauge digital dynamometer, (Instrutherm - model DD-300), and the results will be expressed in newtons. The patient will be instructed to perform the movements of elbow flexion and knee flexion and extension, resisted by a steel cable coupled to the dynamometer. The measurement will be repeated five times with an interval of 1 min between attempts, and the highest value among the three closest measurements will be recorded [44].

Sample size calculation

This is a superiority trial in which sample size determination was performed through prior study [45] information based on the primary PADL variable. With the expectation of an increase in the number of steps of 45% (approximately 2260 steps) in the FTG compared with the CTG and UTG (both with no expected increase), using a standard deviation of 2603 steps, and loss at follow-up of 20% of individuals (values commonly found in the study population) [44], 25 individuals will be required in each of the three groups to obtain a power of 80%, adopting an α of 5%.

Statistical analysis

The statistical program SPSS 22.0 (IBM, Armonk, NY, USA) will be used. The data will be submitted to the normality test of Kolmogorov–Smirnov, and if they present normal distribution, the descriptive variables will be expressed as mean and standard deviation; if they do not fit the Gaussian distribution model, data will be presented as median and interquartile range. Mauchly’s sphericity test will be performed. Once the sphericity is assumed, two-way analysis of variance (ANOVA) will be performed to evaluate the possible intra- and inter-group differences (FTG, CTG, and UCG) at pre-intervention, post-intervention, and post-follow-up. The Tukey post-hoc will be used to identify the specific differences in the variables in which the F values found are higher than the established statistical significance criterion. To evaluate the effect size between interventions, Cohen’s d test will be used. The level of significance adopted will be 5%. Data integrity will be monitored by regularly scrutinizing data files for omissions and errors. Participants will be given an anonymous study ID to protect confidentiality, and only study investigators will have access to the final trial data set.

Discussion

Potential impact and significance of the study

The present proposal was developed through extensive literature research on this topic. Through the interpretation of the results found in several studies, it was possible to develop this concise and structured training protocol. The use of this protocol in the treatment of COPD will confirm whether the addition of functional physical training to a conventional training will promote positive effects on PADL and functionality and whether there will be maintenance of possible gains at the 3-month post-training follow-up.

Strengths and limitations of the study

This study presents as a strong point the follow-up 3 months after training as this allows evaluation of whether the possible changes resulting from the protocol will be maintained. The assessment of PADL via accelerometers as primary outcome is a strong point as it is an objective measurement and does not suffer influence of personnel involved in the study. Another strong point that can be considered is the fact of this being a randomized clinical trial, which makes the study more reliable. The fact that the study is performed in only one center is considered a limitation, as is the inability to blind the therapists and patients to the training protocol.

Contribution and clinical applicability

The results obtained in the proposed protocol may provide subsidies via publication for the implementation and insertion of a physical training circuit in the rehabilitation of patients with COPD. In addition, the proposed functional exercises are easily applicable and simulate ADLs not requiring specific equipment and therefore can be implemented in several PR centers.

Trial status

Protocol number: RBR-3zmh3r. Recruiting: Study start date: March 7, 2018. Study completion date: December 2019.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s13063-019-3780-y.

Acknowledgments

This study was supported by the São Paulo Research Foundation - FAPESP (grants #2017/10145-7, #2018/ 04871-0, and #2017/10925-2).
Ethical approval has been granted by the human ethics committee of the FCT/UNESP (#77909317.2.0000.5402). Informed consent will be obtained by researchers from all study participants.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3:637–58.CrossRefPubMedPubMedCentral Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3:637–58.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat van den Borst B, Slot IG, Hellwig VA, Vosse BA, Kelders MC, Barreiro E, et al. Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol. 2013;114:1319–28.CrossRefPubMed van den Borst B, Slot IG, Hellwig VA, Vosse BA, Kelders MC, Barreiro E, et al. Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol. 2013;114:1319–28.CrossRefPubMed
3.
Zurück zum Zitat Giacomini M, DeJean D, Simeonov D, Smith A. Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature. Ont Health Technol Assess Ser. 2012;12:1–47.PubMedPubMedCentral Giacomini M, DeJean D, Simeonov D, Smith A. Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature. Ont Health Technol Assess Ser. 2012;12:1–47.PubMedPubMedCentral
4.
Zurück zum Zitat Polkey MI, Rabe KF. Chicken or egg: physical activity in COPD revisited. Eur Respir J. 2009;33:227–9.CrossRefPubMed Polkey MI, Rabe KF. Chicken or egg: physical activity in COPD revisited. Eur Respir J. 2009;33:227–9.CrossRefPubMed
5.
Zurück zum Zitat Ramon MA, Ter Riet G, Carsin AE, Gimeno-Santos E, Agusti A, Anto JM, et al. The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model. Eur Respir J. 2018;52:pii: 1800079 Ramon MA, Ter Riet G, Carsin AE, Gimeno-Santos E, Agusti A, Anto JM, et al. The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model. Eur Respir J. 2018;52:pii: 1800079
6.
Zurück zum Zitat Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:972–7.CrossRefPubMed Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:972–7.CrossRefPubMed
7.
Zurück zum Zitat Vorrink SN, Kort HS, Troosters T, Lammers JW. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res. 2011;12:33.CrossRefPubMedPubMedCentral Vorrink SN, Kort HS, Troosters T, Lammers JW. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res. 2011;12:33.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44:1521–37.CrossRefPubMed Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44:1521–37.CrossRefPubMed
9.
Zurück zum Zitat Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61:772–8.CrossRefPubMedPubMedCentral Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61:772–8.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Gimeno-Santos E, Frei A, Steurer-Stey C, de Batlle J, Rabinovich RA, Raste Y, et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax. 2014;69:731–9.CrossRefPubMed Gimeno-Santos E, Frei A, Steurer-Stey C, de Batlle J, Rabinovich RA, Raste Y, et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax. 2014;69:731–9.CrossRefPubMed
11.
Zurück zum Zitat Garcia-Aymerich J, Serra I, Gomez FP, Farrero E, Balcells E, Rodriguez DA, et al. Physical activity and clinical and functional status in COPD. Chest. 2009;136:62–70.CrossRefPubMed Garcia-Aymerich J, Serra I, Gomez FP, Farrero E, Balcells E, Rodriguez DA, et al. Physical activity and clinical and functional status in COPD. Chest. 2009;136:62–70.CrossRefPubMed
12.
Zurück zum Zitat Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys. 2007;43:475–85.PubMed Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys. 2007;43:475–85.PubMed
13.
Zurück zum Zitat Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131:4s–42s.CrossRefPubMed Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131:4s–42s.CrossRefPubMed
14.
Zurück zum Zitat Maltais F. Exercise and COPD: therapeutic responses, disease-related outcomes, and activity-promotion strategies. Phys Sportsmed. 2013;41:66–80.CrossRefPubMed Maltais F. Exercise and COPD: therapeutic responses, disease-related outcomes, and activity-promotion strategies. Phys Sportsmed. 2013;41:66–80.CrossRefPubMed
15.
Zurück zum Zitat Mccarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;9:Cd003793. Mccarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;9:Cd003793.
16.
Zurück zum Zitat Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–64.CrossRefPubMed Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–64.CrossRefPubMed
17.
Zurück zum Zitat Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Berube C, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:896–901.CrossRefPubMed Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Berube C, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:896–901.CrossRefPubMed
18.
Zurück zum Zitat Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68(Suppl 2):ii1–30.CrossRefPubMed Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68(Suppl 2):ii1–30.CrossRefPubMed
19.
Zurück zum Zitat Garcia-Aymerich J, Pitta F. Promoting regular physical activity in pulmonary rehabilitation. Clin Chest Med. 2014;35:363–8.CrossRefPubMed Garcia-Aymerich J, Pitta F. Promoting regular physical activity in pulmonary rehabilitation. Clin Chest Med. 2014;35:363–8.CrossRefPubMed
20.
Zurück zum Zitat Dallas MI, McCusker C, Haggerty MC, Rochester CL, Zuwallack R. Using pedometers to monitor walking activity in outcome assessment for pulmonary rehabilitation. Chron Respir Dis. 2009;6:217–24.CrossRefPubMed Dallas MI, McCusker C, Haggerty MC, Rochester CL, Zuwallack R. Using pedometers to monitor walking activity in outcome assessment for pulmonary rehabilitation. Chron Respir Dis. 2009;6:217–24.CrossRefPubMed
21.
Zurück zum Zitat Daly CCG, Hennessy E, et al. Effects of neuromuscular electrical stimulation on the activity levels and exercise capacity of patients with moderate to severe COPD. Physiother Pract Res. 2011;32:6–11.CrossRef Daly CCG, Hennessy E, et al. Effects of neuromuscular electrical stimulation on the activity levels and exercise capacity of patients with moderate to severe COPD. Physiother Pract Res. 2011;32:6–11.CrossRef
22.
Zurück zum Zitat Egan C, Deering BM, Blake C, Fullen BM, McCormack NM, Spruit MA, et al. Short term and long term effects of pulmonary rehabilitation on physical activity in COPD. Respir Med. 2012;106:1671–9.CrossRefPubMed Egan C, Deering BM, Blake C, Fullen BM, McCormack NM, Spruit MA, et al. Short term and long term effects of pulmonary rehabilitation on physical activity in COPD. Respir Med. 2012;106:1671–9.CrossRefPubMed
23.
Zurück zum Zitat Mador MJ, Patel AN, Nadler J. Effects of pulmonary rehabilitation on activity levels in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2011;31:52–9.CrossRefPubMed Mador MJ, Patel AN, Nadler J. Effects of pulmonary rehabilitation on activity levels in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2011;31:52–9.CrossRefPubMed
24.
Zurück zum Zitat Probst VS, Kovelis D, Hernandes NA, Camillo CA, Cavalheri V, Pitta F. Effects of 2 exercise training programs on physical activity in daily life in patients with COPD. Respir Care. 2011;56:1799–807.CrossRefPubMed Probst VS, Kovelis D, Hernandes NA, Camillo CA, Cavalheri V, Pitta F. Effects of 2 exercise training programs on physical activity in daily life in patients with COPD. Respir Care. 2011;56:1799–807.CrossRefPubMed
25.
Zurück zum Zitat C-j L, Shiroy DM, Jones LY, Clark DO. Systematic review of functional training on muscle strength, physical functioning, and activities of daily living in older adults. Eur Rev Aging Phys Act. 2014;11:95–106.CrossRef C-j L, Shiroy DM, Jones LY, Clark DO. Systematic review of functional training on muscle strength, physical functioning, and activities of daily living in older adults. Eur Rev Aging Phys Act. 2014;11:95–106.CrossRef
26.
Zurück zum Zitat Lustosa LP, Oliveira LA, LdS S, RdC G, Parentoni AN, Pereira LSM. Efeito de um programa de treinamento funcional no equilíbrio postural de idosas da comunidade. Fisioterapia e Pesquisa. 2010;17:153–6.CrossRef Lustosa LP, Oliveira LA, LdS S, RdC G, Parentoni AN, Pereira LSM. Efeito de um programa de treinamento funcional no equilíbrio postural de idosas da comunidade. Fisioterapia e Pesquisa. 2010;17:153–6.CrossRef
27.
Zurück zum Zitat de Bruin ED, Murer K. Effect of additional functional exercises on balance in elderly people. Clin Rehabil. 2007;21:112–21.CrossRefPubMed de Bruin ED, Murer K. Effect of additional functional exercises on balance in elderly people. Clin Rehabil. 2007;21:112–21.CrossRefPubMed
28.
Zurück zum Zitat Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. Can individualized rehabilitation improve functional independence in elderly patients with COPD? Chest. 2005;128:1194–200.CrossRefPubMed Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. Can individualized rehabilitation improve functional independence in elderly patients with COPD? Chest. 2005;128:1194–200.CrossRefPubMed
29.
Zurück zum Zitat Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–7.CrossRefPubMedPubMedCentral Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–7.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed
31.
Zurück zum Zitat Neder JA, Andreoni S, Castelo-Filho A, Nery LE. Reference values for lung function tests: I. Static volumes. Braz J Med Biol Res. 1999;32:703–17.CrossRefPubMed Neder JA, Andreoni S, Castelo-Filho A, Nery LE. Reference values for lung function tests: I. Static volumes. Braz J Med Biol Res. 1999;32:703–17.CrossRefPubMed
32.
Zurück zum Zitat Carpes MF, Mayer AF, Simon KM, Jardim JR, Garrod R. Versão brasileira da escala London Chest Activity of Daily Living para uso em pacientes com doença pulmonar obstrutiva crônica. J Bras Pneumol. 2008;34:143–51.CrossRefPubMed Carpes MF, Mayer AF, Simon KM, Jardim JR, Garrod R. Versão brasileira da escala London Chest Activity of Daily Living para uso em pacientes com doença pulmonar obstrutiva crônica. J Bras Pneumol. 2008;34:143–51.CrossRefPubMed
33.
Zurück zum Zitat Pitta F, Probst VS, Kovelis D, Segretti NO, Mt Leoni A, Garrod R, et al. Validation of the Portuguese version of the London Chest Activity of Daily Living Scale (LCADL) in chronic obstructive pulmonary disease patients. Rev Port Pneumol. 2008;14:27–47.CrossRefPubMed Pitta F, Probst VS, Kovelis D, Segretti NO, Mt Leoni A, Garrod R, et al. Validation of the Portuguese version of the London Chest Activity of Daily Living Scale (LCADL) in chronic obstructive pulmonary disease patients. Rev Port Pneumol. 2008;14:27–47.CrossRefPubMed
34.
Zurück zum Zitat GOLD 2019. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 Available from: www.goldcopd.org. GOLD 2019. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 Available from: www.​goldcopd.​org.
35.
Zurück zum Zitat Baumann HJ, Kluge S, Rummel K, Klose H, Hennigs JK, Schmoller T, et al. Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial. Respir Res. 2012;13:86.CrossRefPubMedPubMedCentral Baumann HJ, Kluge S, Rummel K, Klose H, Hennigs JK, Schmoller T, et al. Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial. Respir Res. 2012;13:86.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Anunciação PG, Poton R, Szytko A, Polito MD. Comportamento cardiovascular após o exercício resistido realizado de diferentes formas e volumes de trabalho. Rev Bras Med Esporte. 2012;18:117–21.CrossRef Anunciação PG, Poton R, Szytko A, Polito MD. Comportamento cardiovascular após o exercício resistido realizado de diferentes formas e volumes de trabalho. Rev Bras Med Esporte. 2012;18:117–21.CrossRef
37.
Zurück zum Zitat Nicolino J, Ramos D, Leite MR, Rodrigues FMM, de Alencar Silva BS, Tacao GY, et al. Analysis of autonomic modulation after an acute session of resistance exercise at different intensities in chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis. 2015;10:223–9.PubMedPubMedCentral Nicolino J, Ramos D, Leite MR, Rodrigues FMM, de Alencar Silva BS, Tacao GY, et al. Analysis of autonomic modulation after an acute session of resistance exercise at different intensities in chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis. 2015;10:223–9.PubMedPubMedCentral
38.
Zurück zum Zitat Garvey C, Bayles MP, Hamm LF, Hill K, Holland A, Limberg TM, et al. Pulmonary Rehabilitation Exercise Prescription in Chronic Obstructive Pulmonary Disease: Review of Selected Guidelines: an official statement from the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev. 2016;36:75–83.CrossRefPubMed Garvey C, Bayles MP, Hamm LF, Hill K, Holland A, Limberg TM, et al. Pulmonary Rehabilitation Exercise Prescription in Chronic Obstructive Pulmonary Disease: Review of Selected Guidelines: an official statement from the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev. 2016;36:75–83.CrossRefPubMed
39.
Zurück zum Zitat Langer D, Probst V, Pitta F, Burtin C, Hendriks E, Schans C, et al. Guia para prática clínica: fisioterapia em pacientes com Doença Pulmonar Obstrutiva Crônica (DPOC). Braz J Phys Ther. 2009;13:183–204.CrossRef Langer D, Probst V, Pitta F, Burtin C, Hendriks E, Schans C, et al. Guia para prática clínica: fisioterapia em pacientes com Doença Pulmonar Obstrutiva Crônica (DPOC). Braz J Phys Ther. 2009;13:183–204.CrossRef
40.
Zurück zum Zitat Zainuldin R, Mackey MG, Alison JA. Prescription of walking exercise intensity from the 6-minute walk test in people with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2015;35:65–9.CrossRefPubMed Zainuldin R, Mackey MG, Alison JA. Prescription of walking exercise intensity from the 6-minute walk test in people with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2015;35:65–9.CrossRefPubMed
41.
Zurück zum Zitat Wen H, Gao Y, An JY, Chen QL, Zheng JP. Evaluation of exercise intensity for pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Zhonghua jie he he hu xi za zhi. 2007;30:27–30 = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.PubMed Wen H, Gao Y, An JY, Chen QL, Zheng JP. Evaluation of exercise intensity for pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Zhonghua jie he he hu xi za zhi. 2007;30:27–30 = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.PubMed
42.
Zurück zum Zitat Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med. 2000;94:589–96.CrossRefPubMed Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med. 2000;94:589–96.CrossRefPubMed
43.
Zurück zum Zitat Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1428–46.CrossRefPubMed Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1428–46.CrossRefPubMed
44.
Zurück zum Zitat Ramos EM, de Toledo-Arruda AC, Fosco LC, Bonfim R, Bertolini GN, Guarnier FA, et al. The effects of elastic tubing-based resistance training compared with conventional resistance training in patients with moderate chronic obstructive pulmonary disease: a randomized clinical trial. Clin Rehabil. 2014;28:1096–106.CrossRefPubMed Ramos EM, de Toledo-Arruda AC, Fosco LC, Bonfim R, Bertolini GN, Guarnier FA, et al. The effects of elastic tubing-based resistance training compared with conventional resistance training in patients with moderate chronic obstructive pulmonary disease: a randomized clinical trial. Clin Rehabil. 2014;28:1096–106.CrossRefPubMed
45.
Zurück zum Zitat Cruz J, Brooks D, Marques A. Walk2Bactive: A randomised controlled trial of a physical activity-focused behavioural intervention beyond pulmonary rehabilitation in chronic obstructive pulmonary disease. Chron Respir Dis. 2016;13:57–66.CrossRefPubMed Cruz J, Brooks D, Marques A. Walk2Bactive: A randomised controlled trial of a physical activity-focused behavioural intervention beyond pulmonary rehabilitation in chronic obstructive pulmonary disease. Chron Respir Dis. 2016;13:57–66.CrossRefPubMed
Metadaten
Titel
Effects of combining functional exercises with exercise training on daily physical activities and functionality in patients with COPD: a protocol for a randomized clinical trial
verfasst von
Fabiano Francisco de Lima
Carlos Augusto Camillo
Isis Grigoletto
Juliana Souza Uzeloto
Franciele Marques Vanderlei
Dionei Ramos
Ercy Mara Cipulo Ramos
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
Trials / Ausgabe 1/2019
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3780-y

Weitere Artikel der Ausgabe 1/2019

Trials 1/2019 Zur Ausgabe